M. Bonsignore (Palermo, Italy), J. Verbraecken (Edegem, Belgium)
Ghrelin and impaired glucose tolerance in obstructive sleep apnoea I. Papaioannou, M. Patterson, A. Vazir, A. K. Simonds, M. Ghatei, M. J. Morrell, M. I. Polkey (London, United Kingdom)
| |
Metabolic syndrome is frequently associated with obstructive sleep apnea and reflects higher degrees of sleep-disordered breathing M. Ambrosetti, A. Lucioni, S. Conti, R. F. Pedretti, M. Neri (Tradate, Italy)
| |
Leptin, interleukin-6 and tumor necrosis factor-alpha in patients with obstructive sleep apnea syndrome D. Gorecka, J. Chorostowska-Wynimko, M. Bednarek, R. Plywaczewski (Warsaw, Poland)
| |
The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA) R. Rubinsztajn, M. Kumor, K. Byskiniewicz, R. Chazan (Warsaw, Poland)
| |
Determinant factors of serum leptin levels in patients with obstructive sleep apnea F. Kapsimalis, G. Varouchakis, A. Manousaki, D. Nikita, K. Gourgoulianis (Athens, Larissa, Greece)
| |
Insulin resistance and insulin sensitivity in patients with sleep apnea syndrome L. Spicuzza, R. Balsamo, V. Asero, N. Ciancio, R. Polosa, G. Di Maria (Catania, Italy)
| |
Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome X. Zhang, K. Yin (Nanjing, China)
| |
Obstructive sleep apnea syndrome in obese patients: adiponectin levels R. Bossi, C. Baldessari, P. S. Morpurgo, B. Masserini, E. Orsi (Milan, Italy)
| |